Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Inspection Decisions To Be Swayed By Facility "History" With Foreign Regulators

ine conveyor for labeling and packaging ampoules in boxes

Related Content

US FDA Quality Metrics Initiative Continues Moving Forward … Quietly

Apr 23 2018

PDUFA V ‘Program’ Gets Positive Evaluation – Except For Inspections

Apr 02 2015

GDUFA II: Inspection Information Takes Center Stage

Dec 23 2015

FDA, EU To Redouble Inspection Of Asian Pharmaceutical Supply Chains

May 25 2017

Generic User Fee Agreement Includes FDA Pledge To Determine Best Use Of Foreign Regulator Inspections

Dec 07 2011

Leader Of US FDA's EU Mutual Recognition Effort Departs For Industry

Aug 01 2018

Probable Carcinogen Found Haunting More Firms’ Valsartan API

Aug 13 2018

New PIC/S Guide Offers Framework For Voluntary Reliance On Foreign GMP Inspections

May 18 2018

US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen

Jan 18 2017

Agencies, Industry Look to Standardize, Focus Global Inspection Processes

Jul 26 2012

Additional Topics

United States Manufacturing FDA Regulation BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window